Predictive biomarkers for 5‐ALA‐PDT can lead to personalized treatments and overcome tumor‐specific resistances

BACKGROUND: Photodynamic therapy (PDT) is a minimally invasive, clinically approved therapy with numerous advantages over other mainstream cancer therapies. 5‐aminolevulinic acid (5‐ALA)‐PDT is of particular interest, as it uses the photosensitiser PpIX, naturally produced in the heme pathway, follo...

Descripción completa

Detalles Bibliográficos
Autores principales: Mastrangelopoulou, Maria, Grigalavicius, Mantas, Raabe, Tine H., Skarpen, Ellen, Juzenas, Petras, Peng, Qian, Berg, Kristian, Theodossiou, Theodossis A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780429/
https://www.ncbi.nlm.nih.gov/pubmed/32737955
http://dx.doi.org/10.1002/cnr2.1278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780429/
https://www.ncbi.nlm.nih.gov/pubmed/32737955
http://dx.doi.org/10.1002/cnr2.1278

Ejemplares similares